Potent Anti-Tumor Activity of IGM-8444, an Agonist DR5 IgM, Displays Strong Synergy with Chemotherapy and Inducers of Apoptosis

Festival of Biologics USA – March 29 to April 1, 2021

Bruce Keyt, PhD, Chief Scientific Officer
IGM Biosciences, Inc., 325 E Middlefield Road, Mountain View, CA 94043

Festival of Biologics BKeyt 2021

Posted in publications.